LIFECORE BIOMEDICAL INC (LFCR)
US5147661046 - Common Stock
| 2023 (2023-5-28) | 2022 (2022-5-29) | 2021 (2021-5-30) | 2020 (2020-5-31) | 2019 (2019-5-26) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 19.09M | 1.60M | 1.30M | 400.00K | 1.10M | |||
| Receivables | 29.02M | 48.20M | 70.00M | 76.20M | 69.60M | |||
| Inventories | 40.84M | 66.80M | 69.70M | 66.30M | 54.10M | |||
| Other Current Assets | 4.92M | 7.10M | 7.40M | 14.20M | 8.30M | |||
| Total Current Assets | 93.88M | 123.70M | 148.30M | 157.10M | 133.00M | |||
| Non-Current Assets | ||||||||
| PPE Net | 138.67M | 127.10M | 200.40M | 217.70M | 200.00M | |||
| Investments And Advances | N/A | N/A | 45.10M | 56.90M | 61.10M | |||
| Goodwill | 13.88M | 13.90M | 69.40M | 69.40M | 76.70M | |||
| Intangibles | 4.20M | 10.10M | 36.10M | 38.10M | 45.20M | |||
| Other Non-Current Assets | 2.92M | 3.00M | 3.60M | 2.20M | 2.90M | |||
| Total Non-Current Assets | 159.67M | 154.10M | 354.60M | 384.20M | 386.10M | |||
| TOTAL ASSETS | 253.54M | 277.80M | 502.90M | 541.30M | 519.10M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 40.00M | 29.00M | 77.40M | 52.00M | |||
| Current Portion Of LT Debt. | 703.00K | 101.50M | 100.00K | 11.70M | 9.90M | |||
| Accrued Expenses | 12.43M | 18.60M | 24.10M | 23.30M | 20.70M | |||
| Accounts Payable | 22.10M | 15.80M | 47.60M | 51.60M | 54.00M | |||
| Other Current Liabilities | 4.05M | 900.00K | 1.10M | 400.00K | 600.00K | |||
| Total Current Liabilities | 39.29M | 176.80M | 101.90M | 164.40M | 137.10M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 104.28M | 0.00 | 168.20M | 104.80M | 90.70M | |||
| Deferred Taxes/Income | 380.00K | 100.00K | 6.10M | 13.60M | 19.40M | |||
| Other Non-Current Liabilities | 74.51M | 10.20M | 23.90M | 27.50M | 1.70M | |||
| Total Non-Current Liabilities | 179.17M | 10.30M | 198.20M | 145.90M | 111.80M | |||
| TOTAL LIABILITIES | 218.46M | 187.10M | 300.10M | 310.30M | 248.90M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -178.54M | -76.10M | 38.60M | 71.20M | 109.70M | |||
| Additional Paid In Capital | 174.28M | 167.40M | 165.50M | 162.60M | 160.30M | |||
| Minority Interest | N/A | N/A | N/A | N/A | 0.00 | |||
| Common Shares | 39.35M | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Shareholders' Equity | 0.00 | -600.00K | -1.40M | -2.80M | 100.00K | |||
| Shares Outstanding | 30.32M | 29.50M | 29.30M | 29.20M | 29.10M | |||
| Tangible Book Value per Share | -0.74 | 2.26 | 3.32 | 4.23 | 5.09 | |||
| Total Shareholders' Equity | 35.09M | 90.70M | 202.80M | 231.00M | 270.10M | |||
| TOTAL LIABILITIES AND EQUITY | 253.54M | 277.80M | 502.90M | 541.30M | 519.10M | |||
| Statistics | ||||||||
| Debt/Equity | 2.97 | N/A | 0.97 | 0.79 | 0.53 | |||
| Current Ratio | 2.39 | 0.70 | 1.46 | 0.96 | 0.97 | |||
| Return On Assets (ROA) | -39.27% | -41.29% | -6.50% | -7.06% | 0.08% | |||
| Return On Equity (ROE) | -283.75% | -126.46% | -16.12% | -16.54% | 0.15% | |||
| Return On Invested Capital (ROIC) | N/A | N/A | 0.99% | N/A | 1.97% | |||
| Return On Invested Capital Ex Cash (ROICexc) | N/A | N/A | 1.00% | N/A | 1.97% | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexcg) | N/A | N/A | 1.32% | N/A | 2.74% | |||
All data in USD